Perrigo | PRGO - Actif À Court Terme





Actif À Court Terme Changement Date
AbbVie USD 29.06B 523M 2025-12
Abbott USD 26B 1.16B 2025-12
Bayer EUR 32.91B 30M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Coherus Biosciences USD 206.71M 254.25M 2025-12
Corcept Therapeutics USD 485.46M 55.67M 2025-12
Dr.Reddys Laboratories INR 297.55B 18.03B 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
J&J USD 55.62B 1.01B 2025-12
Merck USD 47.56B 10.49B 2025-09
Nestle CHF 31.97B 1.46B 2025-12
Pacira USD 547.97M 14.78M 2025-12
Perrigo USD 2.8B 81.8M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Phibro Animal Health USD 862.18M 26.39M 2025-12
Prestige Brands USD 433.43M 63.98M 2025-12
Reckitt Benckiser GBP 4.6B 287M 2024-12
Sanofi EUR 30.95B 3.09B 2025-12
Supernus Pharmaceuticals USD 644.18M 50.29M 2025-12
Teva Pharmaceutical Industries USD 13.95B 1.21B 2025-12
Xeris Pharmaceuticals USD 240.31M 16.3M 2025-12
Zoetis USD 6.77B 185M 2025-12